Main Menu

News and features 

Read the latest stories about our world-leading research, science, fundraising and philanthropy

To find out more, you can contact our media team, follow us on social media or visit our press release archive.


Sign up for our newsletters


News

Scientists use AI to identify new drug combination for children with incurable brain cancer 22
Sep
2021

Scientists have used artificial intelligence-enhanced tools to successfully propose a new combination of drugs for use against an incurable childhood brain cancer. Find out more

Drug combination shows promise in treatment-resistant advanced ovarian cancer 19
Sep
2021

A new combination of targeted drugs for a type of ovarian cancer has shown promising results in an early clinical trial – shrinking tumours in half of patients. Find out more

Abiraterone keeps men with prostate cancer at risk of spreading alive for longer 19
Sep
2021

Giving the drug abiraterone alongside standard hormone therapy helps men with high-risk prostate cancer, that has not spread elsewhere in the body, live longer. Find out more

See all news articles

Features

A visionary research leader, ally and mentor - Professor Paul Workman steps down as CEO 27
Aug
2021

As Professor Paul Workman steps down as Chief Executive of The Institute of Cancer Research, London, colleagues from the ICR and beyond share memories of and reflections on his impact in cancer research. Find out more

Celebrating the ICR’s achievements under Professor Paul Workman’s leadership 24
Aug
2021

Professor Paul Workman steps down as Chief Executive of The Institute of Cancer Research. Here, we look back at a selection of the many ICR achievements during his leadership. Find out more

Taking on the challenge of treating sarcomas 19
Jul
2021

In the UK, sarcoma diagnoses make up more than 1% of all cancer cases. But sarcomas are hard to understand and treat, and outcomes for patients with advanced disease remain poor – they are cancers of urgent unmet need. Sarcomas are a major focus for our scientists, who are forging new collaborations and opening up fresh avenues for research and treatment. Find out more

See all feature articles